US Army Selects Premier Biomedical, Inc. for Cure for Traumatic Brain Injury, Clinical Depression, and Suicide …

El Paso, TX, August 1, 2013 Premier Biomedical, Inc. (BIEI)

On July 10, 2013, Premier Biomedical, Inc. and the US Army hosted a joint press conference in El Paso, Texas to announce their new partnership and a potential breakthrough cure for traumatic brain injury and suicidal ideation. Army Lieutenant Colonel Shawna Scully, chief neurologist of the William Beaumont Army Medical Center, and Premier Biomedical, Inc.s CEO William A. Hartman spoke at the announcement ceremony.

Army Lt. Col. Dr. Shawna Scully, chief neurologist at WBAMC, commented on the history of traumatic brain injury and suicidal ideation and the alarming prevalence of these cases among active duty military and veterans. Scully noted that initial laboratory testing indicates that Premier Biomedicals technology may be effective in removing the molecules that cause such neurological problems for soldiers with brain injuries.

Scully also commented on the separate but recent achievement by Premier Biomedical, Inc. and the University of Texas at El Paso in developing a drug therapy for mice with breast cancer that greatly outperformed chemotherapy in its early trials.

Highlights of the Joint Conference can be found at http://www.youtube.com/watch?v=pvXUphEbEuM. Full length videos of the conference and of individual speakers can be found on the Premier Biomedical, Inc. YouTube Channel and website.

About Premier Biomedical, Inc. Premier Biomedical, Inc. is a research-based company that intends to discover and develop medical treatments for humans, in collaboration with the University of Texas at El Paso and US Department of Defense, specifically targeting the treatment of Alzheimer's Disease, Fibromyalgia, Multiple Sclerosis, Traumatic Brain Injury, Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig's Disease), Blood Sepsis and Viremia, and Cancer. Premier has licensed the technology behind multiple provisional patents in the United States and a PCT Europe National Patent in the areas of Cancer, Sepsis, and Multiple Sclerosis. Founded in 2010, Premier is headquartered in El Paso, Texas, with offices in Pennsylvania. The Companys common stock trades on the fully reporting Over-The-Counter Bulletin Board under the ticker symbol BIEI. http://www.premierbiomedicalinc.com/

Safe Harbor Notice

Certain statements contained herein are forward-looking statements (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.

Contact Premier Biomedical, Inc. William A. Hartman, CEO (814) 786-8849 info@premierbiomedicalinc.com

SOURCE Premier Biomedical, Inc.

See the article here:
US Army Selects Premier Biomedical, Inc. for Cure for Traumatic Brain Injury, Clinical Depression, and Suicide ...